Supreet Sethi - Publications

Discovery of endothelial cell antibodies associated with pediatric and adult kidney allograft rejection and assessment of a non-human leukocyte antigen antibody assay.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 16, 2025

Kidney transplantation between identical twins with APOL1 homozygote risk alleles - a case report.

Journal: Frontiers in nephrology

Published: June 16, 2025

Novel therapies for treatment of antibody-mediated rejection of the kidney.

Journal: Current opinion in organ transplantation

Published: December 29, 2022

An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.

Journal: Transplantation

Published: August 01, 2022

A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.

Journal: Kidney international

Published: July 14, 2022

Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: November 30, 2021

Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients.

Journal: Transplantation

Published: September 28, 2021

Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts.

Journal: Kidney international reports

Published: June 07, 2021

Approach to Highly Sensitized Kidney Transplant Candidates and a Positive Crossmatch.

Journal: Advances in chronic kidney disease

Published: May 29, 2021

Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 26, 2021

Infectious Complications in Tocilizumab-treated Kidney Transplant Recipients.

Journal: Transplantation

Published: February 03, 2021

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy.

Journal: Kidney international reports

Published: May 21, 2020